European approval is based on robust Phase III data showing Cosentyx provided rapid symptom relief from as early as Week 4, with response rates continuing to improve up to 1 year1,3-5
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone
5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Subscribe To Our Newsletter & Stay Updated
